Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 672,515 |
|
|||||
| News | - | ||||||
| Day High | 18.84 | Low High |
|||||
| Day Low | 18.2598 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kiniksa Pharmaceuticals Ltd | KNSA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.17 | 0.92% | 18.72 | 16:32:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 18.49 | 18.2598 | 18.84 | 18.72 | 18.55 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,539 | 672,515 | US$ 18.63 | US$ 12,531,991 | - | 10.645 - 22.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:30:00 | average | 73,708 | US$ 18.72 | USD |
Kiniksa Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.32B | 70.62M | - | 270.26M | 14.08M | 0.20 | 93.83 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kiniksa Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KNSA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.10 | 18.84 | 17.04 | 17.88 | 450,937 | 1.62 | 9.47% |
| 1 Month | 19.23 | 19.23 | 16.56 | 17.67 | 374,148 | -0.51 | -2.65% |
| 3 Months | 18.39 | 22.10 | 16.56 | 19.39 | 380,411 | 0.33 | 1.79% |
| 6 Months | 15.56 | 22.10 | 14.12 | 18.24 | 430,949 | 3.16 | 20.31% |
| 1 Year | 10.76 | 22.10 | 10.645 | 17.25 | 437,563 | 7.96 | 73.98% |
| 3 Years | 16.63 | 22.10 | 7.36 | 14.24 | 393,170 | 2.09 | 12.57% |
| 5 Years | 15.60 | 33.00 | 5.01 | 15.31 | 354,055 | 3.12 | 20.00% |
Kiniksa Pharmaceuticals Description
| Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. |
